Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Vimian Group AB operates in the veterinary services industry, focusing on providing a range of specialized products and solutions for animal health. The company offers products and services across four key segments: Specialty Pharma, Diagnostics, Veterinary Services, and MedTech. These segments provide pharmaceuticals, diagnostic equipment, technology solutions, and veterinary services aimed at enhancing animal health and treatment. Founded in Sweden, Vimian Group AB is headquartered in Stockholm, from where it extends its operations globally. The company's strategic positioning is strengthened by its comprehensive range of products and services, allowing it to address diverse needs in the veterinary sector and support veterinarians through innovative solutions.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Vimian Group ABEli Lilly
Last price
kr 41.15$1,417.54
Currency
SEK
USD
kr 22B$1.3T
53.6546.01
kr 0.77$30.81
1.130.45
0$6.69
00.49%
Sector
HealthHealth
Employees
1,03350,000
Ticker
Skr VIMIAN$LLY
Primary listing
XSTONYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in SkrVIMIAN or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.